Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNABW) Enterprise Value (2019 - 2025)

Historic Enterprise Value for Ginkgo Bioworks Holdings (DNABW) over the last 7 years, with Q3 2025 value amounting to -$111.1 million.

  • Ginkgo Bioworks Holdings' Enterprise Value rose 8197.62% to -$111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$111.1 million, marking a year-over-year increase of 8197.62%. This contributed to the annual value of -$561.6 million for FY2024, which is 4051.6% up from last year.
  • Ginkgo Bioworks Holdings' Enterprise Value amounted to -$111.1 million in Q3 2025, which was up 8197.62% from -$203.6 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Enterprise Value high stood at -$111.1 million for Q3 2025, and its period low was -$1.7 billion during Q3 2021.
  • For the 5-year period, Ginkgo Bioworks Holdings' Enterprise Value averaged around -$884.4 million, with its median value being -$944.1 million (2023).
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 47039.72% in 2022, then surged by 8197.62% in 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Enterprise Value (Quarter) stood at -$1.5 billion in 2021, then increased by 11.57% to -$1.3 billion in 2022, then increased by 28.25% to -$944.1 million in 2023, then soared by 40.52% to -$561.6 million in 2024, then surged by 80.22% to -$111.1 million in 2025.
  • Its last three reported values are -$111.1 million in Q3 2025, -$203.6 million for Q2 2025, and -$312.4 million during Q1 2025.